Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BioChem Therapeutic synthesizes antiangiogenic fumagillin analogues

Sep. 24, 1997

More new taxoids from Rhone-Poulenc Rorer

Sep. 24, 1997

Protein farnesyltransferase inhibitors prepared at Schering-Plough

Sep. 24, 1997

NCI to fund clinical trials of Pharmacyclics' Gd-Tex

Sep. 22, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

Vaccine for colorectal cancer enters phase I/II

Sep. 22, 1997

Scotia signs licensing agreements for Foscan

Sep. 22, 1997

NCI sponsors trials of new treatment for MDR in multiple myeloma

Sep. 22, 1997

New antiapoptosis gene identified at Yale

Sep. 19, 1997

Advisory committee recommends approval of Photofrin for early-stage NSCLC

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...